Medical 3D printing at the point of care: a regulatory comparison

In this editorial piece, Henry Pinchbeck of 3D LifePrints (Liverpool, UK) compares the key regulatory issues regarding 3D printing in medicine at the point of care facing the UK, EU and USA, in collaboration with Sam Murray of Olympus Regulatory Solutions (PA, USA). Biography: 3D LifePrints is a leading personalized surgery and medical 3D printing company. Its focus is the design and manufacture of patient-specific medical devices. 3D LifePrints’ unique selling proposition is that it provides its services from embedded facilities at the point of care within host hospitals, allowing the clinicians direct access to the full range of 3D…

To view this content, please register now for access

It’s completely free

Source link

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *